China Issues Raft Of Regulatory Notices: Guidelines, Standards And More Reforms
Executive Summary
The January 2019 Asian Medtech Associations Regulatory Networking discussions focus on the volume of activity within China’s agencies in issuing guidances, technical standards, and in review updates. This series is hosted by Medtech Insight, along with the Asia Regulatory and Quality Consultancy (ARQon) and the Asia Regulatory Professionals Association (ARPA).
You may also be interested in...
Chinese Medtech Contracting And Liability Changes From 1 June
China has amended its 2014 primary regulation governing medical devices. The new version of the Regulation on Supervision and Administration of Medical Devices comes into force on 1 June, says Todd Liao of Morgan Lewis.
Dynamic China Moves Into The Fast Lane Of Medtech Regulatory Improvements
The Chinese medtech regulatory system was a key theme at the MedTech Summit in June, where regional specialists gave updates on registration timelines and electronic submissions, and signaled how the world’s biggest market-in-waiting is speeding up its regulatory improvements in a bid to become more open and less forbidding for overseas entrants.
ASEAN Updates For Malaysia, Vietnam: Asian Medtech Associations Regulatory Networking
The latest Asian Medtech Associations Regulatory Networking discussions extended to news from Malaysia, Vietnam, Singapore and ASEAN Medical Device Directive ratification, as well as the recent update from China. This series is hosted by Medtech Insight, along with the Asia Regulatory and Quality Consultancy (ARQon) and the Asia Regulatory Professionals Association (ARPA).